MedTrace Logo

Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian

NCT04081571 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1080

Last updated 2022-03-10

No results posted yet for this study

Summary

Getting a rough indicator about the prevalence of different grade of severity of NAFLD (NASH \& liver fibrosis), and Correlate the severity of fatty liver with different serological risk factors of metabolic syndrome and diseases progression as well as the prevalence of hepatocellular carcinoma related to NAFLD with the use of ; nutritional assessment designed and conducted by the investigators in this research, simple blood test (lipid profile and blood sugar), and easy cheap non-invasive radiological tool as screening to predict NASH.

Conditions

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • Mansoura University

    collaborator OTHER

  • Alexandria University

    collaborator OTHER

  • Fayoum University

    collaborator OTHER

  • Tanta University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Cairo University

    lead OTHER

Principal Investigators

  • Mona A Hegazy, MD · Professor of Internal Medicine Hepatology, Faculty of medicine, Cairo University

  • Ahmed M Abdul Ghani, MD · Lecturer of Internal Medicine & Hepatology, Faculty of Medicine, Cairo University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04081571 on ClinicalTrials.gov